Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

Fri, 16th Apr 2021 15:17

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News:

----------

Tesco PLC - Welwyn Garden City, England-based grocer - Chair John Allan buys 44,426 shares at GBP2.25, worth GBP100,000 on Wednesday. Non-Executive Director Steve Golsby buys 8,608 shares at GBP2.25, worth GBP19,393, on Thursday.

----------

Dechra Pharmaceuticals PLC - Cheshire-based veterinary products - Tony Griffin, managing director of Dechra Veterinary Products EU, sells 25,000 shares at GBP38.52, worth GBP962,950, on Friday. Dechra says Griffin's sale is to widen his investment portfolio for long-term financial planning purposes. He continues to hold 45,650 shares.

----------

OptiBiotix Health PLC - York, England-based developer of compounds to treat obesity, high cholesterol, diabetes and skincare - Non-Executive Director Stephen Hammond buys 25,000 shares at 51.8 pence, worth GBP12,950, on Thursday. The purchase is his only holding, having joined the board in February. Hammond is a UK member of Parliament.

----------

4D Pharma PLC - Leeds-based live biotherapeutic products - Chief Executive Officer Duncan Peyton and Chief Scientific Officer Alex Stevenson take part in company's USD25.0 million equity raise in March. Peyton and Stevenson each subscribe for 658,840 shares at GBP1.10, together worth GBP1.4 million. Peyton now has 9.5 million shares, a 5.3% stake, and Stevenson 9.4 million.

----------

Power Metal Resources PLC - metals exploration and development in Africa, US and Canada - Chief Executive Paul Johnson buys 500,000 shares at 2.39p each, GBP11,957 in total, on Thursday. Johnson had bought another 500,000 shares on Thursday that was already reported, for a GBP23,452 total investment. He now has 62.5 million shares, a 5.5% stake.

----------

Parsley Box Group PLC - Edinburgh-based ready-meal deliveries - Non-Executive Chair Chris van der Kuyl and wife Heather buy 26,165 shares at GBP1.86 to GBP2.03, worth about GBP50,000, on April 1 and April 12. Van der Kuyl now holds 2.3 million shares directly and 1.6 million indirectly via 4J Studios Ltd, for a 9.4% total stake. Parsley listed on AIM on March 31 at an initial public offering price of 200p.

----------

InnovaDerma PLC - London-based beauty, personal care and life science products firm - Non-Executive Director Mark Ward buys 171,242 shares at 40.7p, worth GBP69,695, on Thursday. Ward now has 2.3 million shares, a 13.5% stake. He also has agreed to subscribe to 1.4 million new shares as part of InnovaDerma's placing announced back in January. Finance Director Andrew Dunderdale buys 24,937 shares at 40.1p, also on Thursday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2021 08:54

4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug

4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug

Read more
3 Feb 2021 11:19

4D Pharma makes progress with MRx0518 development programme

(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced progress on activities in its development programme for its lead immuno-oncology single strain 'live biotherapeutic' candidate MRx0518 on Wednesday.

Read more
3 Feb 2021 10:50

SMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward

SMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward

Read more
3 Feb 2021 09:01

4D Pharma Says MRx0518 Part B Study Enrolment Continues To Progress

4D Pharma Says MRx0518 Part B Study Enrolment Continues To Progress

Read more
18 Dec 2020 10:13

4D Pharma Joins Landmark Study For Parkinson's Treatment Development

4D Pharma Joins Landmark Study For Parkinson's Treatment Development

Read more
26 Nov 2020 10:53

4D Pharma Files US Registration Statement For ADR Programme

4D Pharma Files US Registration Statement For ADR Programme

Read more
9 Nov 2020 17:28

IN BRIEF: 4d Pharma Reports Positive Data From Ongoing MRx051 Trials

IN BRIEF: 4d Pharma Reports Positive Data From Ongoing MRx051 Trials

Read more
22 Oct 2020 15:42

IN BRIEF: 4D Pharma Proposes Merger With Longevity Acquisition

IN BRIEF: 4D Pharma Proposes Merger With Longevity Acquisition

Read more
22 Oct 2020 11:06

UK WINNERS & LOSERS SUMMARY: Shaftesbury Down 13% Amid Fundraise Plans

UK WINNERS & LOSERS SUMMARY: Shaftesbury Down 13% Amid Fundraise Plans

Read more
7 Oct 2020 11:25

4D Pharma Reports Positive Results From Bowel Syndrome Treatment Trial

4D Pharma Reports Positive Results From Bowel Syndrome Treatment Trial

Read more
30 Sep 2020 12:04

IN BRIEF: 4D Pharma Interim Loss Widens On R&D Costs Increase

IN BRIEF: 4D Pharma Interim Loss Widens On R&D Costs Increase

Read more
23 Sep 2020 19:22

UK EXECUTIVE CHANGE SUMMARY: Primorus Adds Three Directors To Board

UK EXECUTIVE CHANGE SUMMARY: Primorus Adds Three Directors To Board

Read more
26 Aug 2020 10:40

UK WINNERS & LOSERS SUMMARY: Provident Financial Up On Better Outlook

UK WINNERS & LOSERS SUMMARY: Provident Financial Up On Better Outlook

Read more
26 Aug 2020 09:41

4D Pharma Says Results In MRx0518, Keytruda Cancer Trial "Encouraging"

4D Pharma Says Results In MRx0518, Keytruda Cancer Trial "Encouraging"

Read more
13 Jul 2020 18:25

UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech

UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.